Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
AVENIO ctDNA Surveillance Kit
Durvalumab
+1 more
Locations
1
United States
Stanford University
Stanford, California, United States
Start Date
April 8, 2021
Primary Completion Date
December 30, 2026
Completion Date
December 30, 2026
Last Updated
February 10, 2026
NCT06043817
NCT07144280
NCT07431827
NCT06758401
NCT06427941
NCT06476808
Lead Sponsor
Stanford University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions